Ameritas Investment Partners’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Ameritas Investment Partners’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,928	Closed	-$5K	–	3356
2022 Q1	$5K	Hold	4,928	–	–	﹤0.01%	2982
2021 Q4	$4K	Hold	4,928	–	–	﹤0.01%	3070
2021 Q3	$4K	Hold	4,928	–	–	﹤0.01%	3059
2021 Q2	$8K	Hold	4,928	–	–	﹤0.01%	2967
2021 Q1	$10K	Hold	4,928	–	–	﹤0.01%	2880
2020 Q4	$6K	Hold	4,928	–	–	﹤0.01%	2958
2020 Q3	$6K	Hold	4,928	–	–	﹤0.01%	2955
2020 Q2	$6K	Hold	4,928	–	–	﹤0.01%	2939
2020 Q1	$4K	Hold	4,928	–	–	﹤0.01%	2888
2019 Q4	$5K	Hold	4,928	–	–	﹤0.01%	2910
2019 Q3	$7K	Hold	4,928	–	–	﹤0.01%	2873
2019 Q2	$7K	Hold	4,928	–	–	﹤0.01%	2902
2019 Q1	$8K	Hold	4,928	–	–	﹤0.01%	2780
2018 Q4	$7K	Hold	4,928	–	–	﹤0.01%	2795
2018 Q3	$9K	Hold	4,928	–	–	﹤0.01%	2876
2018 Q2	$9K	Buy	+4,928	New	+$9.17K	﹤0.01%	2874

Other funds holding MBII

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Ameritas Investment Partners's MBII Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2022, closing a stake of 4,928 shares — an estimated $5K sold.

Ameritas Investment Partners first reported a position in MBII in Q2 2018 and held it in 16 quarters. The position peaked at $10K in Q1 2021. 62 funds tracked by Wall St. Rank hold MBII as of Q2 2022.

Ameritas Investment Partners reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 4,928 Marrone Bio Innovations, Inc. shares in Q2 2022, an estimated $5K.
Ameritas Investment Partners first reported a position in Marrone Bio Innovations, Inc. in Q2 2018 and held it in 16 quarters.
Ameritas Investment Partners's Marrone Bio Innovations, Inc. position peaked at $10K in Q1 2021.
62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.